Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies
Bispecific T cell engagers (BiTEs) are an innovative class of immunotherapeutics that redirect T cells to tumor surface antigens. While efficacious against certain hematological malignancies, limited bioavaila...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Johannes P. W. Heidbuechel and Christine E. Engeland Tags: Review Source Type: research
More News: Cancer & Oncology | Hematology